home > °ÀǽÅû > ÆÐÅ°Áö°ÀÇ
°Á¸í |
½ÇÀüÀÓ»ó¾àÇÐ 5 [½Å°æÁúȯ/Á¤½Å Áúȯ/¸é¿ª Áúȯ] |
°Á¼Ұ³ |
º» °ÀǸ¦ ¼ö°ÇÏ´Â Àϼ± ¾à»ç´ÔµéÀº ¼±ÁøÀÓ»ó¾àÇп¡ ´ëÇÑ °³³ä°ú Áö½ÄÀ» ȹµæÇÏ¿© ¾à¹« ÇöÀå¿¡¼ ȯÀÚ¿¡ ´ëÇÑ Ä¡·á¸¦ °ÈÇÏ°í À̸¦ ½ÇÁ¦ÀûÀ¸·Î Àû¿ëÇÔÀ¸·Î½á ¾à±¹ °æ¿µ°ú Á÷´ÉÀÇ Àü¹®¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. °¢ °úÁ¤Àº Áúȯ º° º´Å»ý¸®, ÀÓ»óÁõ»ó, ¾à¹°Ä¡·á¸¦ Áß½ÉÀ¸·Î °ÀÇ°¡ ÁøÇàµÇ¸ç, º» °ÀÇ [ÀÓ»ó¾àÇÐ Session 5 ½Å°æ/Á¤½Å/¸é¿ª]Àº Áúȯº° º» °Á·ΠµÎÅë, ¼ö¸éÀå¾Ö, °£Áú, ¿ì¿ïÁõ, ÆÄŲ½¼º´, ¾ËÃ÷ÇÏÀ̸Ó, °üÀý¿°, ¸é¿ª µîÀÇ ¼¼ºÎÀûÀÎ Áö½ÄÀ» ½ÀµæÇÒ ¼ö ÀÖ´Â °ÁÂÀÔ´Ï´Ù. ¹Ì±¹ ¾àÇдëÇп¡¼ ÆʵðÇÐÀ§¸¦ ÃëµæÇÏ°í ÇöÀç ±¹³» Á¦¾à»ç, º´¿ø, ¾à±¹, ´ëÇп¡¼ ¿Õ¼ºÇÏ°Ô È°µ¿ ÁßÀÎ ±³¼öÁøÀÌ ÁÖÃàÀÌ µÇ¾î Áö±Ý±îÁö ¹è¿ì°í ÀÍÇû´ø ¼±ÁøÀÓ»ó¾àÇÐ Áö½Ä°ú ½ÇÁ¦ ±Ù¹«ÇöÀå¿¡¼ üµæÇÑ ½ÇÀü °æÇèÀ» ¹ÙÅÁÀ¸·Î Àϼ± ¾à»ç´Ôµé¿¡°Ô °ÀǸ¦ Á¦°ø ÇÕ´Ï´Ù. [°»ç¼Ò°³] ±èÁ¾À± Pharm.D. - °æÈñ´ëÇб³ ¾àÇаú Á¹¾÷ - °æÈñ´ëÇб³ ´ëÇпø ¼®»ç - University of Florida, Pharm.D. - Àü) ³ì½ÊÀÚ °³¹ßÆÀ - Àü) ¼¿ï¾Æ»êº´¿ø ¾àÁ¦ÆÀ - Çö) »ç°ú³ª¹« Àӻ󿬱¸¼Ò ¿¬±¸¿ø ¼Èñ³² Pharm.D. - °æÈñ´ëÇб³ ¾àÇаú Á¹¾÷ - University of Florida, Pharm.D. - Çö) ¾àÇÐ ´ëÇÐ Ãâ° - Çö) °ºÏ»ï¼ºº´¿ø ¾àÁ¦°ú ÀÓÇöÁ¤ Pharm.D., BCOP - ¼÷¸í¿©´ë ¾àÇаú Á¹¾÷ - University of Florida, Pharm.D. - Board of Pharmaceutical Specialties, Oncology Pharmacy Àü) ¼÷¸í¿©´ë, ´ö¼º¿©´ë ¾àÇдëÇÐ Ãâ° Çö) »ï¼º¼¿ïº´¿ø ¾àÁ¦ºÎ ±è±â¿µ Pharm.D. - ÀÌÈ¿©ÀÚ´ëÇб³ ¾àÇаú Á¹¾÷ - University of Florida, Pharm.D.(Candiate) - Çö) Pfizer Korea District manager À¯±â¿¬ Pharm.D. - µ¿´ö¿©ÀÚ´ëÇб³ ¾àÇаú Á¹¾÷ - ¼÷¸í¿©ÀÚ´ëÇб³ ÀÓ»ó¾àÇдëÇпø ¼®»ç - U. Of Florida, Pharm.D. - Çö) µ¿´ö¿©ÀÚ´ëÇб³ ¾àÇаú ±³¼ö |
°Á ±â°£/°¡°Ý |
30 / 200,000¿ø |
±³Àçºñ |
10,000¿ø |
°Á¸ñÂ÷ |
1) Epilepsy 2) Evaluation of Patients with Psychiatric Disorders 3) Child / adolescent ADHD 4) Alcohol Abuse 5) Parkinsons disease & Alzheimer disease 6) Depression & MDD & Schizo 7) Bipolar & Anxiety & Eating disorder 8) Osteoarthritis & Gout 9) Rheumatoid Arthritis 10) HIV 11) Immunization 12) Headache 13) CNS Infections 14) Sleep disorders 15) Pain management |